Journal
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume 126, Issue 1, Pages 198-204Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.jid.5700013
Keywords
-
Categories
Ask authors/readers for more resources
Previous studies report that selected topical isoflavonoids are immunoprotective in both mice and humans, when applied following UV irradiation. Isoflavonoids have documented antioxidant activity, but their mechanism of immunomodulation remains unclear. This study examines whether photoimmunoprotection by the isoflavonoids might result from their interaction with one cutaneous antioxidant known to modulate UV photodamage, metallothionein (MT). In mice bearing a null mutation for MT-I and -II, we found that photoimmunoprotection by the isoflavonoid 4',7-dihydroxyisoflavane ( equol) against solar-simulated UV radiation (SSUV) or exogenous cis-urocanic acid was abrogated. Topical equol did not activate MT expression in normal mouse skin, but markedly enhanced the increase in MT expression in murine epidermis following SSUV irradiation. Normal human skin, unlike murine, expressed MT in the basal epidermis. Following SSUV irradiation, topical application of the related synthetic isoflavonoid NV-07 alpha to human skin also markedly enhanced epidermal MT expression. The NV-07 alpha a has been reported previously to protect humans against the UV suppression of Mantoux reactions. Thus, epidermal MT expression appears to protect against photoimmunosuppression in both human and mouse skin. We speculate that equol and its related derivative NV-07 alpha may activate the MT gene synergistically with SSUV, to produce the enhanced immunoprotective effect.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available